Loading...
Chemical structure of Imlunestrant

GC69268

Imlunestrant

Also known as (5R)-5-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-8-(trifluoromethyl)-5H-chromeno[4,3-c]quinolin-2-ol

Imlunestrant (LY-3484356) is an orally effective and selective estrogen receptor (ER) degrader (SERD) with pure antagonistic properties· Imlunestrant can sustainably inhibit ER-dependent gene transcription and cell growth· Imlunestrant can be used in the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid carcinoma (EEC)

ChemicalCAS2408840-26-4MW524.51FormulaC29H24F4N2O3
CAS number
2408840-26-4
Molecular weight
524.51
Formula
C29H24F4N2O3
Solubility
DMSO ： 250 mg/mL (476·64 mM; Need ultrasonic)
InChIKey
UVBQMXOKKDCBJN-MUUNZHRXSA-N
Catalogue number
GC69268
Brand
GLPBIO
Computed properties PubChem CID 146603228 · XLogP 6 · TPSA 54.8 Ų · H-bond donors 1
XLogP
6
TPSA
54.8 Ų
H-bond donors
1
H-bond acceptors
9
Rotatable bonds
6
Heavy atoms
38

SMILES C1C(CN1CCOC2=CC=C(C=C2)[C@@H]3C4=C5C=CC(=CC5=NC=C4C6=C(O3)C=C(C=C6)C(F)(F)F)O)CF

Computed descriptors from PubChem (CID 146603228), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.